Gene-editing Reduces Triglycerides, Cholesterol by Up to 50 Percent, Finds Penn Animal Study
Perelman School of Medicine at the University of PennsylvaniaBlood plasma samples from a mouse that received the Angptl3 CRISPR treatment (right) and a mouse that was untreated (left). The cloudiness of the sample on the left is from the high content of cholesterol and triglycerides.